Comparability preview
Build the board report — $49 →
The Adenoid Cystic Carcinoma Research
EIN 206745475 · MA · NTEE H12 · revenue $1,893,545 · FY 2023-12-31
$
Pick the role and type the pay your board is considering — everything below updates as you type. We only compare against the same role.
50th percentile
We compared this Executive Director / CEO's pay to 18 similar medical research nonprofits of about the same size, adjusted for MA cost of living and inflation.
JEFFREY A KAUFMAN · reported title "EXECUTIVE DIRECTOR/BOARD C".
How we chose them
Every comparable organization in the band — 18 in total — matched by Same NTEE sector (H12), nationwide + budget 0.71–1.4× revenue, and selected by rule, not hand-picked. Peer pay is normalized to MA cost of living (BEA Regional Price Parities) and to the subject's filing year (CPI-U). Full methodology →
| Organization | State | Revenue | Total comp | Filing |
|---|---|---|---|---|
| Food Allergy Fund | NY | $1,915,611 | $293,018 | 990 → |
| Paris Brain Institute America Inc | NY | $1,985,780 | $19,534 | 990 → |
| Orthopaedic Foot & Ankle Foundation | IL | $1,701,279 | $42,806 | 990 → |
| Fox Chase Cancer Center Foundation | PA | $2,092,287 | $67,237 | 990 → |
| Runway To Hope Inc | FL | $1,672,877 | $90,637 | 990 → |
| 🔒 +13 more comparable organizations — the full peer set, sources, and CSV export are included in your board report. | ||||
Generate the board-ready determination
A formatted PDF with the full 18-organization peer set, the distribution, the methodology, and ready-to-adopt 26 CFR 53.4958-6 board-minutes language — timestamped to attach to your minutes. A screenshot of a webpage isn't board minutes.